2.1000
17-May-24 15:59:25
15 minutes delayed
Stocks
+0.0100
+0.48%
Today's range
2.0600 - 2.1607
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire